Roctavian

Genentech Veteran Named New BioMarin CEO as Gene Therapy Launch Ramps Up

BioMarin Pharmaceutical CEO Jean-Jacques Bienaimé will retire in December, when he will be succeeded by Genentech CEO Alexander Hardy. The transition comes with BioMarin in the early stages of the commercial launch of Roctavian, the first FDA-approved hemophilia A gene therapy.

By Frank Vinluan

BioPharma, Pharma

FDA Approves BioMarin Pharma’s Gene Therapy, the First for Hemophilia A

The FDA approved Roctavian for treating hemophilia A. The regulatory decision makes the BioMarin Pharmaceutical product the first gene therapy for this inherited bleeding disorder.

By Frank Vinluan

The Top 5 Home Care Franchise Opportunities in the U.S.

The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.

By HomeWell Care Services

The 5 Best Medical Billing Outsourcing Companies

Medical billing is a tedious administrative task, but outsourcing it may be the key to increased revenue. Explore the top medical billing outsourcing companies and the benefits of partnering with one.

By Global healthcare resource

Solving Healthcare’s Provider Data Problem Starts with Interoperability

Break down the silos. Take control of your provider data.

By ProviderTrust